Assembly Biosciences, Inc.
Balance Sheet
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $58.5M | $38.3M | $19.8M | $52.4M | $45.6M | $59.4M | $46.7M | $41.5M |
| Accounts Receivable | $974.0K | $0 | $43.0K | $944.0K | $336.0K | $1.2M | $3.4M | $2.4M |
| Inventory | — | — | — | — | — | — | — | — |
| Total Current Assets | $254.5M | $115.5M | $133.8M | $97.0M | $154.2M | $224.5M | $282.8M | $222.5M |
| Property, Plant & Equipment | $221.0K | $284.0K | $385.0K | $743.0K | $1.1M | $1.6M | $1.8M | $557.0K |
| Goodwill | — | — | — | — | — | $12.6M | $12.6M | $12.6M |
| Intangible Assets (Excl. Goodwill) | — | — | — | — | — | — | — | — |
| Total Assets | $257.6M | $119.2M | $136.8M | $101.8M | $191.1M | $283.3M | $339.9M | $268.0M |
| Liabilities | ||||||||
| Accounts Payable | $1.2M | $585.0K | $461.0K | $2.5M | $2.7M | $4.6M | $1.7M | $3.7M |
| Total Current Liabilities | $48.8M | $47.8M | $39.2M | $16.3M | $16.1M | $24.4M | $24.4M | $18.5M |
| Long-Term Debt | — | — | — | — | — | — | — | — |
| Total Liabilities | $50.8M | $85.8M | $95.7M | $19.1M | $22.1M | $42.7M | $66.7M | $57.4M |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-832.0M | $-825.9M | $-785.7M | $-724.5M | $-631.4M | $-501.6M | $-439.4M | $-341.8M |
| Total Stockholders' Equity | $206.8M | $33.4M | $41.1M | $82.7M | $168.9M | $240.6M | $273.2M | $210.7M |